Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget - United States
doi 10.18632/oncotarget.13417
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of BRCA1 and BRCA2 Mutation Carriers

Breast Cancer Research
Cancer ResearchOncology
2020English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers

Current Oncology
Oncology
2014English

Physical Activity and the Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy